IP Library Granted Patent US 9,402,881
Granted Patent B2
US 9,402,881 · App. 14/603,504 · Granted Aug 2, 2016

Tissue regeneration and wound treatment methods with platelet derived compositions

Inventor: Mark T. Roedersheimer (Aurora, CO)
Assignee: The Regents of the University of Colorado, a body corporate
A61K38/1866A61K35/19A61K38/1808A61K38/1841A61K38/1858A61L15/40A61L26/0057A61L27/3616A61L27/60C07K14/475
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,402,881
App. No.
14/603,504
Granted
Aug 2, 2016
Kind
B2
Abstract

This invention provides methods for extracting platelets, compositions obtained therefore, and methods for using the same.

Claims (14)

1. A method for regenerating a tissue or treating a wound in a subject, said method comprising contacting a desired site for tissue regeneration or the wound in a subject with a composition comprising a growth factor, wherein said composition is produced by a process comprising:

disrupting pelletized platelets in an extraction solution to produce an insoluble material portion and the extraction solution comprising a growth factor; and

removing insoluble materials and proteins having molecular weight of 2 kD or less from said extraction solution to produce a composition comprising a growth factor.

2. The method of claim 1 , wherein said process further comprises subjecting said extraction solution to an ultrafiltration process to remove any microorganisms that maybe present.

3. The method of claim 2 , wherein said process further comprises lyophilizing said extraction solution to produce a solid composition comprising the growth factor.

4. The method of claim 3 , wherein said process further comprises dissolving said solid composition in a solution to produce a fluid composition comprising the growth factor.

5. The method of claim 1 , wherein said growth factor comprises VEGF, TGF-β1, TGF-β2, PDGF-BB, EGF, or a mixture thereof.

6. The method of claim 1 , wherein the desired site for tissue regeneration comprises a burn site, a graft donor site, an oral and maxillofacial surgery site, a mucogingival surgery site, a perioplastic surgery site, an oral mucosa site, or a combination thereof.

7. A method for reducing a risk of microbial infection in a wound area of a subject, said method comprising treating the wound area of a subject with a wound treatment composition produced by a process comprising:

disrupting pelletized platelets in a solution to produce an insoluble material portion and an extraction solution; and

removing insoluble materials and proteins having molecular weight of 2 kD or less from said extraction solution to produce a wound treatment composition.

8. The method of claim 7 , wherein said process further comprises subjecting said extraction solution to an ultrafiltration process to remove any microorganisms that maybe present.

9. The method of claim 8 , wherein said process further comprises lyophilizing said extraction solution to produce a solid wound treatment composition.

10. The method of claim 9 , wherein said process further comprises dissolving said solid wound treatment composition in a solution to produce a solution of wound treatment composition.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2018
From: REGENTS OF THE UNIVERSITY OF COLORADO
To: ROEDERSHEIMER, MARK
Reel/Frame 047122/0753 →
CONFIRMATORY LICENSE Recorded Jul 7, 2016
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039101/0035 →
Continuity (4)
Continuation 13645525 · Oct 5, 2012
Continuation 12682782
Provisional Application 60980159 · Oct 15, 2007
Related Publication 20150150942A1 · Jun 4, 2015